Bone marrow and splenocyte coculture-generated cells enhance allograft survival

Transplantation

Volumn 64, Issue 1, 1997, Pages 114-123

  Valente, John F ^a   Ogle, Cora K ^a,b   Alexander, J Wesley ^a   Li, Bing Guo ^b   Custer, David A ^a   Noel, J Gregory ^b   Ogle, James D ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE;

ADOPTIVE TRANSFER; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; COCULTURE; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ANIMALS; BLOOD TRANSFUSION; BONE MARROW CELLS; CELL DIVISION; CENTRIFUGATION, DENSITY GRADIENT; COCULTURE TECHNIQUES; DENDRITIC CELLS; GRAFT SURVIVAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LIPOPOLYSACCHARIDES; MACROPHAGES; RATS; RATS, INBRED ACI; RATS, INBRED BN; RATS, INBRED BUF; RATS, INBRED LEW; SPLEEN;

EID: 0030871989     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707150-00021     Document Type: Article

References (40)

1. Hartner WC, Markees TG, De Fazio SR, et al. Effect of early administration of donor bone marrow cells on renal allograft survival in dogs treated with antilymphocyte serum and cyclosporine. Transplantation 1995; 59: 131.
2. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
3. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Transplantation 1995; 59: 1367.
4. Thomas J, Carer M, Cunningham P, et al. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. Transplantation 1987; 43: 332.
5. Tchervenkov JI, Cofer BR, Davies C, Alexander JW. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. Transplantation 1995; 59: 821.
6. Wood ML, Monaco AP, Gottschalk R. Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice. Transplantation 1991; 51: 208.
7. Hartner WC, De Fazio SR, Maki T, et al. Prolongation of renal allograft survival in antilymphocyte-serum-treated dogs by postoperative injection of density-gradient-fractionated donor bone marrow. Transplantation 1986; 42: 593.
8. De Fazio SE, Kowolenko M, Monaco AP, Gozzo JJ. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice. Transplant Proc 1987; 19: 547.
9. De Fazio SR, Hartner WC, Monaco AP, Gozzo JJ. Prolongation of graft survival in ALS-treated mice by donor-specific bone marrow. Transplantation 1987; 43: 564.
10. Sugiura K, Inaba M, Ogata H, et al. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc Natl Acad Sci 1988; 85: 4824.
11. Pourshadi M, De Fazio SR, Gozzo JJ. Abrogation of secondary skin allograft rejection by veto-like cells in donor bone marrow. Transplantation 1993; 56: 385.
12. Maki T, Gottschalk R, Wood ML, Monaco AP. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells. J Immunol 1981; 127: 1433.
13. Verbanac KM, Carver FM, Maisch CE, Thomas JM. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplantation 1994; 57: 893.
14. Holda JH. LPS activation of bone marrow natural suppressor cells. Cell Immunol 1992; 141: 518.
15. MacVittie TJ, Patchen ML, Walker RI. Hematopoietic responses to lipopolysaccharide in C57BL/10Sn and C57BL/10ScN strain mice. Stem Cells 1982; 2: 24.
16. Punjabi CJ, Laskin DL, Heck DE, Laskin JD. Production of nitric oxide by murine bone marrow cells. J Immunol 1992; 149: 2179.
17. Szabolcs P, Avigan D, Gezelter S, et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 1996; 87: 4520.
18. Vandenabeele P, Guisez Y, Declerq W, et al. Response of murine cell lines to an IL-1/IL-2 induced factor in a rat/mouse T hybridoma (PC60): differential induction of cytokines by human IL-1 alpha and IL-1 beta and partial amino acid sequence of rat GM-CSF. Lymphokine Cytokine Res 1990; 9: 381.
19. Angulo I, Rodriguez R, Garcia B, et al. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. J Immunol 1995; 155: 15.
20. Brenan M, Puklavec M. The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J Exp Med 1992; 175: 1457.
21. Salvatierra O, Vincenti F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. Ann Surg 1980; 192: 543.
22. Alexander JW, Babcock GF, First MR, et al. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplantation. Transplantation 1992; 53: 423.
23. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
24. Monaco AP, Wood ML, Maki T, et al. Attempt to induce unresponsiveness to human renal allografts with antilymphocyte globulin and donor-specific bone marrow. Transplant Proc 1985; 17: 1312.
25. Wood ML, Monaco AP, Gozzo JJ, Liegeois A. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1971; 3: 676.
26. Hartner WC, Monaco AP, Gozzo JJ. Effect of timing of bone marrow injection on the prolongation of skin grafts in ALS-treated mice. Transplant Proc 1989; 21: 242.
27. Hartner WC, Shaffer D, Markees TG. Effect of cyclosporine A treatment in induction of donor specific unresponsiveness in mongrel dogs following a short course of ALS and donor bone marrow infusion on canine renal allograft function. Transplant Proc 1991; 23: 477.
28. Hartner WC, Merkees TG, De Fazio SR, et al. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs. Transplantation 1991; 52: 784.
29. Hartner WC, De Fazio SR, Markees TG, et al. Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum. Transplant Proc 1987; 19: 476.
30. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
31. Thomas JM, Verbanac KM, Carver FM, et al. Veto cells in transplantation tolerance. Clin Transplant 1994; 8: 195.
32. Rastellini C, Lu L, Ricordi C, et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
33. Ohzato H, Monaco AP. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 1992; 54: 1090.
34. Shapira OM, Mor E, Reshef T, et al. Prolongation of survival of rat cardiac allografts by T cell vaccination. J Clin Invest 1993; 91: 388.
35. Granger DK, Matas AJ, Jenkins MK, et al. Prolonged survival without posttransplant immunosuppression in a large animal model. Surgery 1994; 116: 236.
36. Blakely ML, Shaffer D, Ohzato H, et al. Indefinite survival following small intestinal transplantation after intrathymic injection of the donor with recipient-type splenocytes in a rat model. Transplantation 1995; 59: 309.
37. Alexander JW, Masroor S, Levy A, Galla K. A new strategy for prolonging xenograft survival. Transplantation 1994; 58: 14.
38. Dono K, Wood ML, Ozato H, et al. Marked prolongation of rat skin xenografts induced by intrathymic injection of xenogeneic splenocytes and a short course of rapamycin in antilymphocyte serum-treated mice. Transplantation 1995; 59: 929.
39. Monaco AP, Wood ML, Gottschalk R, Seiler FR. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells. Transplantation 1991; 51: 213.
40. Kanada K, Tsunoda R, Hamada H. GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity. J Leukoc Biol 1996; 60: 181.